The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The medical marijuana market has seen unprecedented growth in recent years, with no signs of slowing down. This article delves into the factors driving this growth, the trends shaping the market, and the key players involved.

Rapid Market Expansion

Recent Growth

• 2023 to 2024: The market is projected to expand from $27.5 billion in 2023 to $33.3 billion in 2024, achieving a compound annual growth rate (CAGR) of 21.1%.
• Historical Drivers:
  • Changing regulatory landscape
  • Growing acceptance of cannabis for medical purposes
  • Expanding list of medical conditions
  • Patient demand for alternative therapies
  • Evolving attitudes among healthcare providers

Future Projections

• 2024 to 2028: The market is expected to soar to $72.9 billion by 2028, with a CAGR of 21.6%.
• Future Drivers:
  • Continued regulatory developments
  • Advances in scientific research and evidence
  • Increased patient education and awareness
  • Expansion of medical marijuana product offerings
  • Integration into mainstream healthcare

View More On The Medical Marijuana Market Report 2024 – https://www.thebusinessresearchcompany.com/report/medical-marijuana-global-market-report

Key Market Trends

Strategic Partnerships

• Partnerships with Traditional Healthcare Providers: Collaborations are forming to enhance product reach and credibility.
• Focus on Customized Treatment Plans: Tailored solutions are becoming more prevalent to meet specific patient needs.
• Standardization of Dosage and Labeling: Efforts are underway to ensure consistency and reliability in products.
• Investment and M&A Activity: Significant investments and mergers are consolidating the market and fostering innovation.

Impact of Cancer Prevalence

• Cancer Treatment: Medical marijuana is increasingly used to manage symptoms such as neuropathy, nausea, pain, vomiting, appetite loss, and weight loss.
• Rising Demand: With cancer cases on the rise (1.92 million new cases in the US in 2022), the demand for medical marijuana as an adjunctive therapy is growing.

Major Players in the Market

• Top Companies:
  • Pfizer Inc.
  • Curaleaf Holdings Inc.
  • Trulieve Cannabis Corp
  • Green Thumb Industries GTI Inc.
  • Cresco Labs Inc.
  • Tilray Inc.
  • Aphria Inc.
  • Canopy Growth Corporation
  • And many others

Strategic Partnerships

• Teva Pharmaceutical & Tikun Olam-Cannbit: Teva partnered with Tikun Olam-Cannbit in December 2021 to produce and market medical cannabis oils in Israel.
• Trulieve Cannabis Corp. & Connected Cannabis Co: In January 2022, Trulieve expanded its partnership with Connected Cannabis Co. to maintain a portfolio of proprietary top-shelf strains.

Major Acquisitions

• Jazz Pharmaceuticals & GW Pharmaceuticals: In May 2021, Jazz Pharmaceuticals acquired GW Pharmaceuticals, enhancing its portfolio with cannabinoid-based medications.

Market Segmentation

By Product

• Dried Flower
• Extract Form

By Type

• Flower
• Concentrate
• Edibles
• Other Types

By Application

• Pain Management
• Tourette Syndrome
• Alzheimer’s Disease
• Migraines
• Depression and Anxiety
• Multiple Sclerosis
• Cancer
• Other Applications

By Distribution Channel

• Retail Pharmacy
• E-Commerce
• Other Distribution Channels

Regional Insights

• North America: The largest market in 2023.
• Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

Conclusion

The medical marijuana market is on a robust growth trajectory, driven by regulatory changes, scientific advancements, and increasing acceptance among both patients and healthcare providers. Strategic partnerships, acquisitions, and innovations in product offerings are shaping the future of this dynamic market, with significant opportunities for growth and development in the coming years.

Request A Sample Of The Global Medical Marijuana Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=9091&type=smp